<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace コミュニティ:</title>
    <link>http://hdl.handle.net/10098/2399</link>
    <description />
    <pubDate>Tue, 21 May 2013 17:12:04 GMT</pubDate>
    <dc:date>2013-05-21T17:12:04Z</dc:date>
    <item>
      <title>Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET</title>
      <link>http://hdl.handle.net/10098/2403</link>
      <description>タイトル: Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET
著者: YOSHII, Yukie; WAKI, Atsuo; FURUKAWA, Takako; KIYONO, Yasushi; MORI, Tetsuya; YOSHII, Hiroshi; KUDO, Takashi; OKAZAWA, Hidehiko; WELCH, Michael J.; FUJIBAYASHI, Yasuhisa
抄録: Introduction: [1-^&lt;11&gt;C]acetate positron emission tomography (PET) is used for myocardial&#xD;
studies. In the myocardium, mitochondrial acetyl-CoA synthetase (ACSS1) mainly&#xD;
contributes to the radiopharmaceutical uptake. [1-^&lt;11&gt;C]acetate PET is also used for tumor&#xD;
diagnosis; however, the uptake mechanism of radiolabeled acetate in tumors remains unclear.&#xD;
Our previous study reported that cytosolic acetyl-CoA synthetase (ACSS2) was expressed in&#xD;
tumor cells and up-regulated under hypoxia; whereas, expression of ACSS1 was negligible&#xD;
regardless of the oxygen conditions. We also indicated that ACSS2 is a bi-directional enzyme&#xD;
that controls acetyl-CoA / acetate metabolism in tumor cells. In this study, to elucidate the&#xD;
basic mechanism of tumor acetate uptake, we focused on ACSS2 and investigated the role of&#xD;
ACSS2 in the uptake of radiolabeled acetate in tumor cells. Methods: [1-^&lt;14&gt;C]acetate uptake and ACSS2 expression were examined in four tumor cell&#xD;
lines under normoxia or hypoxia. An ACSS2 knockdown study was also performed.&#xD;
Results: [1-^&lt;14&gt;C]acetate uptake was increased in the tumor cells under hypoxia. This pattern&#xD;
followed that of ACSS2 expression. The incorporated ^&lt;14&gt;C was mostly distributed in the&#xD;
lipid-soluble fractions, and this tendency increased under hypoxia. ACSS2 knock down led to&#xD;
a corresponding reduction in [1-^&lt;14&gt;C]acetate uptake in all tumor cell lines examined under&#xD;
normoxia and hypoxia. Conclusions: ACSS2 plays an important role in the uptake of radiolabeled acetate in tumor&#xD;
cells, which is different from that in the myocardium, which mainly involves ACSS1. The&#xD;
uptake of radiolabeled acetate in tumors increased under hypoxia along with up-regulation of&#xD;
ACSS2 expression. This suggests a possible mechanism for acetate PET for tumors.</description>
      <pubDate>Thu, 01 Oct 2009 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10098/2403</guid>
      <dc:date>2009-10-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

